Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

New Approaches to Neuroblastoma Therapy Consortium · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
immunotherapy
neuroblastoma, relapsed neuroblastoma, refractory neuroblastoma, cellular therapy, immunotherapy, chemoimmunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 913808
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.